Optikira LLC
1Patents
1Active
1Granted
39Portfolio score
Filing activity: Aug 31, 2018 → Aug 31, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11649237B2 | Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.